Compare PAA & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAA | PEN |
|---|---|---|
| Founded | 1981 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 10.9B |
| IPO Year | N/A | 2015 |
| Metric | PAA | PEN |
|---|---|---|
| Price | $17.75 | $300.71 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 16 |
| Target Price | $20.40 | ★ $307.19 |
| AVG Volume (30 Days) | ★ 2.4M | 479.9K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | ★ 8.57% | N/A |
| EPS Growth | 8.03 | ★ 367.34 |
| EPS | 1.21 | ★ 4.14 |
| Revenue | ★ $46,917,000,000.00 | $1,333,798,000.00 |
| Revenue This Year | N/A | $16.77 |
| Revenue Next Year | $3.43 | $14.12 |
| P/E Ratio | ★ $17.11 | $72.65 |
| Revenue Growth | N/A | ★ 14.61 |
| 52 Week Low | $15.58 | $221.26 |
| 52 Week High | $21.00 | $310.00 |
| Indicator | PAA | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 69.45 | 67.77 |
| Support Level | $16.73 | $284.95 |
| Resistance Level | $17.60 | $298.69 |
| Average True Range (ATR) | 0.27 | 8.02 |
| MACD | 0.08 | 0.11 |
| Stochastic Oscillator | 81.93 | 91.50 |
Plains All American Pipeline LP through its subsidiaries, engages in the pipeline transportation, terminaling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates through two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, gathering systems, trucks, and barges or railcars. The NGL segment is involved in natural gas processing and NGL fractionation, storage, transportation, and terminalling. It generates the majority of its revenue from the Crude Oil segment.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.